The Efficacy and Safety Profile of Capsaicin 8% Patch Versus 5% Lidocaine Patch in Males With Diabetic Neuropathy
Status:
Completed
Trial end date:
2020-01-02
Target enrollment:
Participant gender:
Summary
The study aims to compare the effectiveness and tolerability of using lidocaine 5% patch to
8% capsaicin patch in patients with diabetic neuropathy. Assessment of analgesic
effectiveness was assessed by observing any change in the Numeric Pain Rating Scale (NPRS)
score, average daily pain Brief Pain Inventory (BPI) for painful diabetic peripheral
neuropathy (BPI-DPN Q4) and Patient Global Impression of Change (PGIC). Assessment of
capsaicin and lidocaine safety and identifying treatment adverse effects were secondary
endpoints in this study